Combinatietherapie erlotinib en bevacizumab bij NSCLC

Delen via:

Log hier in om volledige toegang te krijgen.

Login of Account maken

 



Bronnen:

  1. Zhao BH, Zhang WX Yu DL et al. Erlotinib in combination with bevacizumab has potential benefit in non-small cell lung cancer: A systematic review and meta-analysis of randomized clinical trials. Lung Cancer. https://doi.org/10.1016/j.lungcan.2018.05.011